DNA-Thioguanine (DNA-TG) Is a Promising Novel Method to Predict Adverse Events to Thiopurine in Inflammatory Bowel Disease

Ahmed Bayoumy Bayoumy^{1

2}, Ludovicus Jozef Johannes Derijks^{3

4}, Nanne Klaas Hendrik de Boer^{1

2}

Affiliations

¹ Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
² Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam, The Netherlands.
³ Department of Clinical Pharmacy and Clinical Pharmacology, Máxima Medical Center, Veldhoven, The Netherlands.
⁴ Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center, Maastricht, The Netherlands.

Editorial

Ahmed Bayoumy Bayoumy et al. Inflamm Bowel Dis. 2025.

. 2025 Feb 10;31(2):612-613.

doi: 10.1093/ibd/izae234.

Ahmed Bayoumy Bayoumy^{1

2}, Ludovicus Jozef Johannes Derijks^{3

4}, Nanne Klaas Hendrik de Boer^{1

2}

¹ Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
² Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam, The Netherlands.
³ Department of Clinical Pharmacy and Clinical Pharmacology, Máxima Medical Center, Veldhoven, The Netherlands.
⁴ Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center, Maastricht, The Netherlands.

No abstract available

Comment in

Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?
Sharip MT, Parkes M, Subramanian S. Sharip MT, et al. Inflamm Bowel Dis. 2024 Dec 5;30(12):2521-2522. doi: 10.1093/ibd/izae125. Inflamm Bowel Dis. 2024. PMID: 39011862
Editorial Response to the Letter Relating to our Article "Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?".
Sharip MT, Parkes M, Subramanian S. Sharip MT, et al. Inflamm Bowel Dis. 2025 Feb 10;31(2):614-615. doi: 10.1093/ibd/izae242. Inflamm Bowel Dis. 2025. PMID: 39447023 No abstract available.

Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?
Sharip MT, Parkes M, Subramanian S. Sharip MT, et al. Inflamm Bowel Dis. 2024 Dec 5;30(12):2521-2522. doi: 10.1093/ibd/izae125. Inflamm Bowel Dis. 2024. PMID: 39011862
Editorial Response to the Letter Relating to our Article "Predicting Adverse Events to Thiopurines in IBD: Are We a Step Closer?".
Sharip MT, Parkes M, Subramanian S. Sharip MT, et al. Inflamm Bowel Dis. 2025 Feb 10;31(2):614-615. doi: 10.1093/ibd/izae242. Inflamm Bowel Dis. 2025. PMID: 39447023 No abstract available.